COMMUNIQUÉS West-GlobeNewswire

Le Fonds Rio Tinto Canada investit 2 millions de dollars pour faire avancer l’innovation en santé au Québec
25/08/2026
Le soutien apporté à deux projets novateurs accélérera l’innovation, renforcera les soins aux patients et fera progresser la recherche, à l’échelle mondiale MONTRÉAL, 25 août 2026 (GLOBE NEWSWIRE) -- Le Fonds Rio Tinto [...]
Rio Tinto Canada Fund invests $2 million to advance healthcare innovation in Quebec
25/08/2026
Support for two groundbreaking initiatives will accelerate innovation, strengthen patient care and advance research with global impact MONTREAL, Aug. 25, 2026 (GLOBE NEWSWIRE) -- The Rio Tinto Canada Fund is investing $ [...]
BrewDog cumule les distinctions aux World Beer Awards 2026 et confirme l’excellence de son savoir-faire brassicole
25/08/2026
Les bières Hazy Jane, Wingman et Mackie’s Two Scoops remportent une médaille d’or et le titre de meilleure de leur catégorie en Écosse. Les références Punk IPA, Lost Lager, Black Heart et Mello se distinguent également [...]
Annovis to Host Corporate Update Webinar on September 2, 2026
25/08/2026
MALVERN, Pa., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
25/08/2026
TAIPEI, Taiwan, Aug. 25, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic [...]
CVRx Responds to Letter from Pointillist Family Office
25/08/2026
MINNEAPOLIS, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Mixie Technologies, Inc. (OTC: MIXE) Portfolio Company HoloTwin Unveils TwinRuntime: Enterprise Digital Twins That Run in a Standard Web Browser, No Downloads Required
25/08/2026
Mixie Technologies' flagship portfolio company milestone caps a year that took HoloTwin from a strategic investment, to a CES 2026 award, to HoloTwin 2.0, and now to a browser-native runtime that puts living digital [...]
Nu-Tek BioSciences to Attend BPI East 2026 in Boston, Connecting Animal-Free Culture Media Nutrients with Pharma Customer Growth Strategies
25/08/2026
Nu-Tek will meet with pharmaceutical leadership during BioProcess International East Sept. 22-25 in Boston to discuss 100% animal-origin-free peptones and protein hydrolysates, with a focus on product quality and supply [...]
Nu-Tek BioSciences participera au salon BPI East 2026 à Boston pour établir des liens entre ses nutriments pour milieux de culture sans composants d’origine animale et les stratégies de croissance de ses clients du secteur pharmaceutique
25/08/2026
Nu-Tek rencontrera des dirigeants de l’industrie pharmaceutique lors du salon BioProcess International East, du 22 au 25 septembre à Boston, afin de discuter de peptones et d’hydrolysats de protéines 100 % sans [...]
Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update
25/08/2026
Clinical Development Strategy for Alzheimer’s Disease Remains the Focus as Anavex Advances Regulatory Progress Across All Three Programs Anavex Submits Completed Alzheimer’s Disease Clinical Study Data and Rett Syndrome [...]
4DMT to Participate in Upcoming Investor Conferences
25/08/2026
EMERYVILLE, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
25/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today [...]
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
25/08/2026
Recognition highlights Truvaga’s combination of patented non-invasive vagus nerve stimulation technology, thoughtful design and personalized wellness experience ROCKAWAY, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- [...]
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
25/08/2026
Company on track to initiate SOTERIA trial in the second half of 2026 Clinical development activities advancing following FDA authorization, CRO engagement and Fast Track Designation across all four planned indication [...]
RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer
25/08/2026
PK/PD Data is from a Sub-Study in the Phase III TIGeR-PaC Clinical Trial The Study Shows Approximately 51% Tumor-Site Drug Extraction, Decreased Systemic Exposure, and Significant Correlation Between Drug Metabolite [...]
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
25/08/2026
Average Weekly New Patient Referrals into Vivos’ Nevada Sleep & Airway Medicine Centers Rose 212% Over the Past Six Weeks from the Prior Six Weeks LITTLETON, Colo., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Vivos [...]
Applied Biologics Announces Acceptance of Updated CAMPX XWRAP® Clinical Trial Results for Presentation at SAWC Fall 2026
25/08/2026
Updated analysis of 222-patient randomized controlled trial demonstrates statistically significant improvement in complete diabetic foot ulcer closure with XWRAP plus standard of care SCOTTSDALE, Ariz., Aug. 25, 2026 ( [...]
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
25/08/2026
President & CEO, Sabrina Martucci Johnson, discusses the Company’s shift to commercial stage, upcoming revenue opportunities, Ovaprene’s positive interim Phase 3 results and what could drive value over the next 12– [...]
Olympia Pharmaceuticals Introduces Polidocanol 2% Injection for Targeted Cosmetic Vein Treatment
25/08/2026
New injection gives healthcare providers a comfortable, effective option for cosmetic spider and reticular vein therapies ORLANDO, Fla., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , a premier FDA- [...]

Pages